stockrow
Friday 6 November 2026
Export ZTEKF’s income statement to Excel — free account
Zentek Ltd.
ZTEKF Healthcare Medical Instruments & Supplies
Zentek Ltd.’s revenue for fiscal 2026 (year ended March 2026) was $120,200.00, down 80.8% from fiscal 2025.
- Revenue
- −95.4%
- EPS
- 0.00%
- Free cash flow
- −254.6%
- Total debt
- +6.53%
Quarter to June 2026, against a year earlier
0.37
0.01
+2.78%
Follow ZTEKF
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 4 | 1 | — |
| (52.85%) | (56.47%) | (79.91%) | (53.33%) | ||
| (41.96%) | (44.25%) | (58.57%) | (42.42%) | ||
ROIC |
(45.42%) | (46.37%) | (66.94%) | (68.55%) | |
Return on Tangible Assets |
(66.49%) | (62.96%) | (84.55%) | (38.67%) | |
Average Days of Receivables |
91.11 | 172.02 | 815.94 | 0.00 | |
Free Cash Flow per Share |
(0.02) | (0.02) | (0.02) | (0.04) | |
Free Cash Flow |
(2.51) | (2.80) | (2.46) | (4.56) | |
Capital Expenditures |
1.36 | 1.25 | 1.21 | (0.89) | |
| Other line items | |||||
Cash ROIC |
(23.46%) | (24.61%) | (26.46%) | (14.45%) | |
Accounts Receivable Turnover |
3.80 | 2.71 | 0.21 | 0.00 | |
Accounts Payable Turnover |
0.19 | 0.15 | 0.59 | 0.69 | |
Inventory Turnover |
0.47 | 0.46 | 2.86 | 3.28 | |
Average Days of Payables |
2,481.13 | 2,854.40 | 662.34 | 634.75 | |
Days of Inventory on Hand |
704.14 | 761.66 | 82.02 | 68.05 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
85.13% | 143.99% | 995.59% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
693.11% | 649.20% | 3,245.84% | 0.00% | |
Share Based Compensation of Revenue |
77.65% | 106.86% | 756.41% | 0.00% | |
Interest Coverage |
96.95 | 114.98 | (78.60) | (84.70) | |
Operating CF/Net income |
0.66 | 0.70 | 0.52 | 0.49 | |
Depreciation/Fixed assets |
0.04 | 0.04 | 0.04 | 0.04 | |
Capex/Depreciation |
3.38 | 3.23 | 3.17 | (2.37) | |
Revenue per Share |
0.01 | 0.01 | 0.00 | 0.00 | |
Operating CF per Share |
(0.04) | (0.03) | (0.03) | (0.03) | |
Capex per Share |
0.01 | 0.01 | 0.01 | (0.01) | |
Capex to Sales |
(2.07) | (1.85) | (10.04) | 0.00 |
Columns are period end dates